- Home
- DOCS vs CHWY Comparison
DOCS vs CHWY Comparison
Compare DOCS & CHWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOCS | CHWY |
|---|---|---|
| Founded | 2010 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Catalog/Specialty Distribution |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3B | 13.5B |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | DOCS | CHWY |
|---|---|---|
| Price | $43.65 | $32.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 23 |
| Target Price | ★ $68.05 | $45.86 |
| AVG Volume (30 Days) | 2.9M | ★ 8.0M |
| Earning Date | 02-05-2026 | 12-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.88 | N/A |
| EPS | ★ 1.25 | 0.49 |
| Revenue | $621,329,000.00 | ★ $12,584,235,000.00 |
| Revenue This Year | $15.39 | $8.66 |
| Revenue Next Year | $11.07 | $8.62 |
| P/E Ratio | ★ $34.99 | $66.80 |
| Revenue Growth | ★ 20.21 | 10.00 |
| 52 Week Low | $43.25 | $29.83 |
| 52 Week High | $85.21 | $48.62 |
Technical Indicators
Market Signals| Indicator | DOCS | CHWY |
|---|---|---|
| Relative Strength Index (RSI) | 34.76 | 43.50 |
| Support Level | $43.25 | $31.55 |
| Resistance Level | $44.88 | $33.77 |
| Average True Range (ATR) | 1.26 | 1.24 |
| MACD | 0.44 | -0.10 |
| Stochastic Oscillator | 12.50 | 17.08 |
Price Performance
Historical ComparisonAbout DOCS Doximity Inc.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
About CHWY Chewy Inc.
Chewy is the largest e-commerce petcare retailer in the US, generating $11.9 billion in fiscal 2024 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending time developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods like crates, leashes, and bowls.